These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2774976)

  • 1. Evidence that the fusion protein of respiratory syncytial virus exists as a dimer in its native form. Brief report.
    Arumugham RG; Hildreth SW; Paradiso PR
    Arch Virol; 1989; 106(3-4):327-34. PubMed ID: 2774976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular processing of the human respiratory syncytial virus fusion glycoprotein: amino acid substitutions affecting folding, transport and cleavage.
    Anderson K; Stott EJ; Wertz GW
    J Gen Virol; 1992 May; 73 ( Pt 5)():1177-88. PubMed ID: 1375280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-translational processing and oligomerization of the fusion glycoprotein of human respiratory syncytial virus.
    Collins PL; Mottet G
    J Gen Virol; 1991 Dec; 72 ( Pt 12)():3095-101. PubMed ID: 1765771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty acid acylation of the fusion glycoprotein of human respiratory syncytial virus.
    Arumugham RG; Seid RC; Doyle S; Hildreth SW; Paradiso PR
    J Biol Chem; 1989 Jun; 264(18):10339-42. PubMed ID: 2732224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective mucosal immunization against respiratory syncytial virus using purified F protein and a genetically detoxified cholera holotoxin, CT-E29H.
    Tebbey PW; Scheuer CA; Peek JA; Zhu D; LaPierre NA; Green BA; Phillips ED; Ibraghimov AR; Eldridge JH; Hancock GE
    Vaccine; 2000 Jun; 18(24):2723-34. PubMed ID: 10781860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interprotein disulfide bonding between F and G glycoproteins of human respiratory syncytial virus.
    Arumugham RG; Hildreth SW; Paradiso PR
    Arch Virol; 1989; 105(1-2):65-79. PubMed ID: 2719556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV disease.
    Murphy BR; Sotnikov A; Paradiso PR; Hildreth SW; Jenson AB; Baggs RB; Lawrence L; Zubak JJ; Chanock RM; Beeler JA
    Vaccine; 1989 Dec; 7(6):533-40. PubMed ID: 2692334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinguishing between respiratory syncytial virus subgroups by protein profile analysis.
    Walpita P; Mufson MA; Stanek RJ; Pfeifer D; Connor JD
    J Clin Microbiol; 1992 Apr; 30(4):1030-2. PubMed ID: 1572961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dimerization of matrix protein is required for budding of respiratory syncytial virus.
    Förster A; Maertens GN; Farrell PJ; Bajorek M
    J Virol; 2015 Apr; 89(8):4624-35. PubMed ID: 25673702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of antigenic sites of subtype-specific respiratory syncytial virus attachment proteins.
    Walsh EE; Hall CB; Schlesinger JJ; Brandriss MW; Hildreth S; Paradiso P
    J Gen Virol; 1989 Nov; 70 ( Pt 11)():2953-61. PubMed ID: 2479715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory syncytial virus (RSV) fusion protein subunit F2, not attachment protein G, determines the specificity of RSV infection.
    Schlender J; Zimmer G; Herrler G; Conzelmann KK
    J Virol; 2003 Apr; 77(8):4609-16. PubMed ID: 12663767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic structure, evolution and immunobiology of human respiratory syncytial virus attachment (G) protein.
    Melero JA; García-Barreno B; Martínez I; Pringle CR; Cane PA
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2411-8. PubMed ID: 9349459
    [No Abstract]   [Full Text] [Related]  

  • 13. Polylactosaminoglycan modification of the respiratory syncytial virus small hydrophobic (SH) protein: a conserved feature among human and bovine respiratory syncytial viruses.
    Anderson K; King AM; Lerch RA; Wertz GW
    Virology; 1992 Nov; 191(1):417-30. PubMed ID: 1413513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism.
    Krarup A; Truan D; Furmanova-Hollenstein P; Bogaert L; Bouchier P; Bisschop IJM; Widjojoatmodjo MN; Zahn R; Schuitemaker H; McLellan JS; Langedijk JPM
    Nat Commun; 2015 Sep; 6():8143. PubMed ID: 26333350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of live respiratory syncytial virus priming on the immune response generated by a recombinant vaccine candidate, BBG2Na.
    Goestch L; Plotnicky-Gilquin H; Champion T; Beck A; Haeuw JF; Nguyen T; Bonnefoy JY; Corvaïa N
    Vaccine; 2000 Jun; 18(24):2648-55. PubMed ID: 10781850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cotton rat immune responses to virus-like particles containing the pre-fusion form of respiratory syncytial virus fusion protein.
    Cullen LM; Blanco JC; Morrison TG
    J Transl Med; 2015 Nov; 13():350. PubMed ID: 26541285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for the role of glycoprotein G of respiratory syncytial virus in binding of Neisseria meningitidis to HEp-2 cells.
    Raza MW; Blackwell CC; Ogilvie MM; Saadi AT; Stewart J; Elton RA; Weir DM
    FEMS Immunol Med Microbiol; 1994 Nov; 10(1):25-30. PubMed ID: 7874075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization.
    Murphy BR; Sotnikov AV; Lawrence LA; Banks SM; Prince GA
    Vaccine; 1990 Oct; 8(5):497-502. PubMed ID: 2251875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial protection to respiratory syncytial virus (RSV) elicited in mice by intranasal immunization using live staphylococci with surface-displayed RSV-peptides.
    Cano F; Plotnicky-Gilquin H; Nguyen TN; Liljeqvist S; Samuelson P; Bonnefoy J; Stâhl S; Robert A
    Vaccine; 2000 Jun; 18(24):2743-52. PubMed ID: 10781862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.
    Li X; Sambhara S; Li CX; Ettorre L; Switzer I; Cates G; James O; Parrington M; Oomen R; Du RP; Klein M
    Virology; 2000 Mar; 269(1):54-65. PubMed ID: 10725198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.